Free tool
FAERS Monitor: Entocort Ec
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021324 or its brand name (Entocort Ec, Budesonide). Reports on generic versions are filed under their own applications.
Reports
40,657
Serious
31,583
78% of reports
Hospitalization
15,345
Death reported
3,109
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,894
- dyspnoea4,577
- off label use4,445
- asthma3,630
- fatigue2,606
- condition aggravated2,492
- headache2,438
- diarrhoea2,387
- cough2,245
- pneumonia2,245
- nausea2,110
- wheezing2,025
- pyrexia1,908
- pain1,877
- weight decreased1,715
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 138 |
| 2005 | 220 |
| 2006 | 195 |
| 2007 | 197 |
| 2008 | 282 |
| 2009 | 292 |
| 2010 | 320 |
| 2011 | 533 |
| 2012 | 736 |
| 2013 | 782 |
| 2014 | 978 |
| 2015 | 1,346 |
| 2016 | 1,591 |
| 2017 | 1,682 |
| 2018 | 2,259 |
| 2019 | 2,940 |
| 2020 | 3,524 |
| 2021 | 3,719 |
| 2022 | 4,002 |
| 2023 | 3,975 |
| 2024 | 4,117 |
| 2025 | 4,002 |
| 2026 | 2,827 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,013,502 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| wheezingSignal | 2,025 | 18.3 | 17.5 | 31,972 |
| asthmaSignal | 3,630 | 17.1 | 16.6 | 53,652 |
| condition aggravatedSignal | 2,492 | 4.3 | 4.1 | 6,270 |
| dyspnoeaSignal | 4,577 | 4.2 | 4.1 | 11,410 |
| coughSignal | 2,245 | 4.2 | 4.0 | 5,429 |
| pneumoniaSignal | 2,245 | 3.6 | 3.5 | 4,260 |
| weight decreasedSignal | 1,715 | 3.2 | 3.0 | 2,597 |
| pyrexiaSignal | 1,908 | 2.9 | 2.7 | 2,337 |
| off label useSignal | 4,445 | 2.6 | 2.6 | 4,677 |
| headacheSignal | 2,438 | 2.0 | 1.9 | 1,280 |
| drug ineffective | 4,894 | 1.9 | 1.9 | 2,309 |
| diarrhoea | 2,387 | 1.9 | 1.8 | 1,074 |
| fatigue | 2,606 | 1.7 | 1.7 | 837 |
| pain | 1,877 | 1.6 | 1.5 | 413 |
| nausea | 2,110 | 1.4 | 1.3 | 229 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.